Regulatory Roundup: EMA and the European Monitoring Center for Drugs to Cooperate; And More.
ePT--the Electronic Newsletter of Pharmaceutical Technology
The European Medicines Agency and the European Monitoring Center for Drugs and Drug Addiction to Cooperate.
The European Medicines Agency (EMA) and the European Monitoring Centre for Drugs and Drug Addiction agreed to a working arrangment on June 14, 2010, as part of EMA’s initiative to “cooperate with other European Union bodies for early identification and management of potential conflicts over scientific opinions,” according to an agency press release. The agreement includes fostering cooperation between the two agencies, including sharing information and reports on new psychoactive substances and any misuse of these products.
According to various Chinese media reports, on June 13, 2010, the deputy head of the China State Food and Drug Administration (SFDA), Zhang Jingli, was fired for disciplinary violations. In 2007, the then SFDA Chief Zheng Xiaoyu was executed after an investigation showed that he approved unsafe drugs, which ultimately led to the deaths of some consumers, in exchange for money. An investigation on Zhang is being conducted.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
